Home Product Detail
Active Pharmaceutical Ingredients (APIs)
  • Sorafenib Tosylate*

    • API Product   :   

      Sorafenib Tosylate*

    • CEP   :   

      -

    • WCC   :   

    • Therapeutic Use    :   

      Antineoplastics

    • Originator   :   

      Bayer and Onyx Pharmaceuticals

    • CAS No.    :   

      284461-73-0

    • Trade Name.   :   

      NEXAVAR

    • Molecular Weight   :   

      464.825 g/mol

    • Molecular Formula   :   

      C21H16ClF3N4O3

    Application

    Sorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Sorafenib is used to treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma

    General Description

    Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.

    ENQUIRE WITH US
    send